A Low-Profile Science Discipline Is Buzzing With Activity

Africanized honeybees have not reached the United States yet—the smart money is on their crossing the border from Mexico about February 1990. But these aggressive insects have already turned the bee research community upside down—a classic example of how Nature, every once in a while propels a low-profile scientific discipline into the limelight. While some bee scientists in the field may bemoan the swarms of reporters demanding time-consuming interviews, others seem to enjoy b

Written byJonathan Beard
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Africanized honeybees have not reached the United States yet—the smart money is on their crossing the border from Mexico about February 1990. But these aggressive insects have already turned the bee research community upside down—a classic example of how Nature, every once in a while propels a low-profile scientific discipline into the limelight.

While some bee scientists in the field may bemoan the swarms of reporters demanding time-consuming interviews, others seem to enjoy basking in the sudden attention that, because of the Africanized bees, has been raining, on an otherwise esoteric branch of entomology. The publicity, they feel, could be key in their efforts to gain more foundation support for research. But despite the new visibility, bee specialists claim that research money is not increasing.

The problem with Africanized bees—often referred to as “killer bees,” although entomologists hate the term—began in 1957 when 26 colonies, imported to South America for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies